MaaT Pharma
@maatpharma.bsky.social
MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival.
📅 Rencontrez le management de MaaT Pharma lors du Salon Investir Day le 25 novembre 2025, sur le stand L36 !
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
November 18, 2025 at 11:18 AM
📅 Rencontrez le management de MaaT Pharma lors du Salon Investir Day le 25 novembre 2025, sur le stand L36 !
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
🦠 Eric Soyer prendra la parole lors d’une intervention sur le thème « Construire un leader du microbiote : la stratégie de MaaT Pharma ».
📍 Carrousel du Louvre, 99 rue de Rivoli, 75001 Paris
📅 Fiers de participer au 24ème congrès annuel de la SFGM-TC 2025, à Genève !
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
November 17, 2025 at 11:20 AM
📅 Fiers de participer au 24ème congrès annuel de la SFGM-TC 2025, à Genève !
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
🔬 Nous présenterons à nouveau des données cliniques issues du programme EAP sous la forme d’une communication orale, ainsi que deux posters dédiés à MaaT013 et MaaT033.
🔎 Toutes les informations dans le visuel ci-dessous 👇
📰 [#PressRelease] - MaaT Pharma announces the successful completion of its Global Offering of €9.1 million
👉 www.maatpharma.com/november-14-...
👉 www.maatpharma.com/november-14-...
November 14, 2025 at 10:29 PM
📰 [#PressRelease] - MaaT Pharma announces the successful completion of its Global Offering of €9.1 million
👉 www.maatpharma.com/november-14-...
👉 www.maatpharma.com/november-14-...
📰 [#PressRelease] – MaaT Pharma Launches a Capital Increase of Approximately €9 Million
👉 Read the press release: www.maatpharma.com/november-13-...
👉 Read the press release: www.maatpharma.com/november-13-...
November 13, 2025 at 8:36 PM
📰 [#PressRelease] – MaaT Pharma Launches a Capital Increase of Approximately €9 Million
👉 Read the press release: www.maatpharma.com/november-13-...
👉 Read the press release: www.maatpharma.com/november-13-...
📰 MaaT Pharma To Present Updated Preclinical Data at SITC (@sitcancer.bsky.social) 2025.
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
November 5, 2025 at 6:45 AM
📰 MaaT Pharma To Present Updated Preclinical Data at SITC (@sitcancer.bsky.social) 2025.
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
We’re excited to share promising updated results for MaaT034 showing immune activation and anti-tumor activity in germ-free models.
👉 Full press release: www.maatpharma.com/november-5-2...
📰 [PressRelease] – We’re thrilled to announce that our Phase 3 results evaluating Xervyteg® (MaaT013) in acute Graft-versus-Host Disease (#aGvHD) have been selected for oral presentation at ASH Congress 2025.
👉 Read the full press release: www.maatpharma.com/november-3-2...
👉 Read the full press release: www.maatpharma.com/november-3-2...
November 5, 2025 at 5:09 AM
📰 [PressRelease] – We’re thrilled to announce that our Phase 3 results evaluating Xervyteg® (MaaT013) in acute Graft-versus-Host Disease (#aGvHD) have been selected for oral presentation at ASH Congress 2025.
👉 Read the full press release: www.maatpharma.com/november-3-2...
👉 Read the full press release: www.maatpharma.com/november-3-2...
📄 [#PressRelease] - MaaT Pharma Reports Financial Results for the Third Quarter 2025 and Provides Financing Update
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
November 4, 2025 at 6:53 AM
📄 [#PressRelease] - MaaT Pharma Reports Financial Results for the Third Quarter 2025 and Provides Financing Update
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
📍Next stops: SITC, SFGM-TC, Investir Day, ASH – see you there!
👉 Read the full press release: www.maatpharma.com/november-4-2...
📢 Proud to see our lead candidate MaaT013 highlighted in a new review in Current Opinion in Immunology by E. Godefroy and F. Altare, exploring how the gut microbiota regulates immune responses in acute graft-versus-host disease (#aGvHD).
🔬Open-access article: www.sciencedirect.com/science/arti...
🔬Open-access article: www.sciencedirect.com/science/arti...
October 30, 2025 at 11:28 AM
📢 Proud to see our lead candidate MaaT013 highlighted in a new review in Current Opinion in Immunology by E. Godefroy and F. Altare, exploring how the gut microbiota regulates immune responses in acute graft-versus-host disease (#aGvHD).
🔬Open-access article: www.sciencedirect.com/science/arti...
🔬Open-access article: www.sciencedirect.com/science/arti...
📢 Meet Sheri Simmons, Acting Chief Scientific Officer at MaaT Pharma, during the Annual Meeting of the SITC in National Harbor, Maryland, USA.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
October 28, 2025 at 11:02 AM
📢 Meet Sheri Simmons, Acting Chief Scientific Officer at MaaT Pharma, during the Annual Meeting of the SITC in National Harbor, Maryland, USA.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
🔬 On Friday, November 7, Sheri will present our preclinical findings on MaaT034, our next generation co-cultured microbiome ecosystem therapy candidate.
📢 Join MaaT Pharma as an 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗜𝗻𝘁𝗲𝗿𝗻 (𝗠/𝗙)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
October 20, 2025 at 2:30 PM
📢 Join MaaT Pharma as an 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗜𝗻𝘁𝗲𝗿𝗻 (𝗠/𝗙)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎓 6-month internship – starting early 2026
📍 Saint-Quentin-Fallavier (France)
📢 Join MaaT Pharma as an R&D Project Manager (M/F)!
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
October 17, 2025 at 12:27 PM
📢 Join MaaT Pharma as an R&D Project Manager (M/F)!
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
🎯 Do you have strong project management experience in the pharmaceutical or biotech industry and a passion for innovation in oncology and microbiome research? This opportunity is for you!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📢 [#Internship] – Join MaaT Pharma as a Quality Assurance Intern (M/F)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
October 15, 2025 at 11:32 AM
📢 [#Internship] – Join MaaT Pharma as a Quality Assurance Intern (M/F)!
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
📩 Interested? Send your CV and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Full job description: www.maatpharma.com/wp-content/u...
📅 6-month internship – starting January/February 2026
📍 Lyon (France)
📢 Join MaaT Pharma as a Biological Collection Project Manager (M/F)!
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
October 14, 2025 at 1:50 PM
📢 Join MaaT Pharma as a Biological Collection Project Manager (M/F)!
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
📩 Send your resume and a short motivation email to careers@maat-pharma.com to apply now!
🔬 Detailed job description: www.maatpharma.com/wp-content/u...
#ProjectManagement #Biotech #Microbiome #Production #Quality #Regulatory
📢 Noémie Laurent, Chargée des ressources humaines chez MaaT Pharma, et Michèle Boyer de Zordi, chargée de Mission RSE et HSE, seront présentes au Forum emploi des industries de santé 2025, le 9 octobre à Lyon.
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
October 8, 2025 at 10:04 AM
📢 Noémie Laurent, Chargée des ressources humaines chez MaaT Pharma, et Michèle Boyer de Zordi, chargée de Mission RSE et HSE, seront présentes au Forum emploi des industries de santé 2025, le 9 octobre à Lyon.
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
👉 Contribuez à faire avancer la science du microbiote : www.forumemploi-industriessante.fr
📰 [PressRelease] - We’re proud to share that the DSMB has issued a positive recommendation following the second safety interim analysis of our Phase 2b PHOEBUS trial evaluating MaaT033 in patients receiving allo-HSCT.
👉 Read the full press release here: www.maatpharma.com/october-7-20...
👉 Read the full press release here: www.maatpharma.com/october-7-20...
October 7, 2025 at 5:44 AM
📰 [PressRelease] - We’re proud to share that the DSMB has issued a positive recommendation following the second safety interim analysis of our Phase 2b PHOEBUS trial evaluating MaaT033 in patients receiving allo-HSCT.
👉 Read the full press release here: www.maatpharma.com/october-7-20...
👉 Read the full press release here: www.maatpharma.com/october-7-20...
📅 Frederic Fasano, Directeur Stratégie et Développement Corporate chez MaaTPharma interviendra à la conférence annuelle du Musée de sciences biologiques Docteur Mérieux : « Vivre en Intelligences avec les Microbes ».
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
October 3, 2025 at 9:20 AM
📅 Frederic Fasano, Directeur Stratégie et Développement Corporate chez MaaTPharma interviendra à la conférence annuelle du Musée de sciences biologiques Docteur Mérieux : « Vivre en Intelligences avec les Microbes ».
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
👉Plus d’informations : www.musee-docteur-merieux.com/conference-f...
📅 Emilie Plantamura, Directrice Médicale adjointe chez MaaT Pharma, interviendra lors du symposium « Développer une médecine du microbiote pour restaurer la symbiose hôte-microbes », organisé dans le cadre des Entretiens Jacques Cartier 2025.
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
October 2, 2025 at 3:00 PM
📅 Emilie Plantamura, Directrice Médicale adjointe chez MaaT Pharma, interviendra lors du symposium « Développer une médecine du microbiote pour restaurer la symbiose hôte-microbes », organisé dans le cadre des Entretiens Jacques Cartier 2025.
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
👉Inscrivez-vous ici : www.billetweb.fr/developper-u...
📅 Join Eric Soyer, CFO at MaaT Pharma, and Guilhaume Debroas, our Head of Investor Relations, at the Portzamparc Groupe BNP Paribas’ digital Biotech & Health Seminar 2025, on October 1, 2025.
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
September 29, 2025 at 2:42 PM
📅 Join Eric Soyer, CFO at MaaT Pharma, and Guilhaume Debroas, our Head of Investor Relations, at the Portzamparc Groupe BNP Paribas’ digital Biotech & Health Seminar 2025, on October 1, 2025.
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
#Biotech #Health #Investments #DigitalEvent #Investors #LifeSciences #Microbiome #Pharma #Portzamparc
🎥 [Media] À l’occasion de la publication de nos résultats semestriels, notre Directeur Financier Eric Soyer est revenu sur nos derniers jalons créateurs de valeur pour Arnaud Bivès - Boursier.com.
👉 Lire l’interview complète : www.boursier.com/actions/actu...
👉 Lire l’interview complète : www.boursier.com/actions/actu...
September 23, 2025 at 3:11 PM
🎥 [Media] À l’occasion de la publication de nos résultats semestriels, notre Directeur Financier Eric Soyer est revenu sur nos derniers jalons créateurs de valeur pour Arnaud Bivès - Boursier.com.
👉 Lire l’interview complète : www.boursier.com/actions/actu...
👉 Lire l’interview complète : www.boursier.com/actions/actu...
📅 Meet Eric Soyer, Chief Financial Officer at MaaT Pharma, and Guilhaume Debroas, Head of Investor Relations at MaaT Pharma, at KBC Securities' Life Sciences Conference on Thursday, September 25, 2025, in Brussels.
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC
September 22, 2025 at 10:06 AM
📅 Meet Eric Soyer, Chief Financial Officer at MaaT Pharma, and Guilhaume Debroas, Head of Investor Relations at MaaT Pharma, at KBC Securities' Life Sciences Conference on Thursday, September 25, 2025, in Brussels.
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC
#IR #Investors #Finance #Microbiome #Innovation #Pharma #Science #Healthcare #KBC
🩸 For #BloodCancerAwarenessMonth, we spotlight the gut microbiome: a key player in immunity and cancer care. Microbiotherapies in trials aim to restore balance, boost treatment efficacy, and reduce post-transplant complications.
👉 Learn more: www.maatpharma.com/patients-car...
👉 Learn more: www.maatpharma.com/patients-car...
September 19, 2025 at 10:08 AM
🩸 For #BloodCancerAwarenessMonth, we spotlight the gut microbiome: a key player in immunity and cancer care. Microbiotherapies in trials aim to restore balance, boost treatment efficacy, and reduce post-transplant complications.
👉 Learn more: www.maatpharma.com/patients-car...
👉 Learn more: www.maatpharma.com/patients-car...
📢 [Euronext Indices] - MaaT Pharma (Euronext Paris: MAAT) has been included in the CAC Small, CAC Mid & Small, and CAC All-Tradable indices following the annual review of the Euronext Paris indices.
#Euronext #Indices #CAC #Innovation #Microbiome #Oncology
#Euronext #Indices #CAC #Innovation #Microbiome #Oncology
September 18, 2025 at 2:54 PM
📢 [Euronext Indices] - MaaT Pharma (Euronext Paris: MAAT) has been included in the CAC Small, CAC Mid & Small, and CAC All-Tradable indices following the annual review of the Euronext Paris indices.
#Euronext #Indices #CAC #Innovation #Microbiome #Oncology
#Euronext #Indices #CAC #Innovation #Microbiome #Oncology
📄 [Press release] - MaaT Pharma Publishes its Half Year 2025 Financial Results and Provides a Business Update
👉 Read the full press release for more information: www.maatpharma.com/september-17...
#BusinessUpdate #FinancialResults #Oncology #Microbiome #aGvHD #Hematology
👉 Read the full press release for more information: www.maatpharma.com/september-17...
#BusinessUpdate #FinancialResults #Oncology #Microbiome #aGvHD #Hematology
September 17, 2025 at 5:57 AM
📄 [Press release] - MaaT Pharma Publishes its Half Year 2025 Financial Results and Provides a Business Update
👉 Read the full press release for more information: www.maatpharma.com/september-17...
#BusinessUpdate #FinancialResults #Oncology #Microbiome #aGvHD #Hematology
👉 Read the full press release for more information: www.maatpharma.com/september-17...
#BusinessUpdate #FinancialResults #Oncology #Microbiome #aGvHD #Hematology
📅 [Event] – Join Guilhaume Debroas, Head of Investor Relations at MaaT Pharma, at the 8th edition of the #investor Forum Lyon Pole Bourse.
📍 Palais de la Bourse – Place de la Bourse, Lyon, France
🗓 September 23, 2025
#LyonPoleBourse #LyonForum2024 #InvestInBiotech #HealthcareInvestors
📍 Palais de la Bourse – Place de la Bourse, Lyon, France
🗓 September 23, 2025
#LyonPoleBourse #LyonForum2024 #InvestInBiotech #HealthcareInvestors
September 16, 2025 at 3:11 PM
📅 [Event] – Join Guilhaume Debroas, Head of Investor Relations at MaaT Pharma, at the 8th edition of the #investor Forum Lyon Pole Bourse.
📍 Palais de la Bourse – Place de la Bourse, Lyon, France
🗓 September 23, 2025
#LyonPoleBourse #LyonForum2024 #InvestInBiotech #HealthcareInvestors
📍 Palais de la Bourse – Place de la Bourse, Lyon, France
🗓 September 23, 2025
#LyonPoleBourse #LyonForum2024 #InvestInBiotech #HealthcareInvestors
📅 Proud to sponsor the 16th edition of the #SFGMTC workshops on harmonizing practices in transplantation and cell therapy!
Join Alex Kiss, our Medical Science Liaison, to discuss on innovative strategies to improve patient survival following allo-HSCT.
📍 Espace Inkermann Chatillon, Lille, France
Join Alex Kiss, our Medical Science Liaison, to discuss on innovative strategies to improve patient survival following allo-HSCT.
📍 Espace Inkermann Chatillon, Lille, France
September 15, 2025 at 2:55 PM
📅 Proud to sponsor the 16th edition of the #SFGMTC workshops on harmonizing practices in transplantation and cell therapy!
Join Alex Kiss, our Medical Science Liaison, to discuss on innovative strategies to improve patient survival following allo-HSCT.
📍 Espace Inkermann Chatillon, Lille, France
Join Alex Kiss, our Medical Science Liaison, to discuss on innovative strategies to improve patient survival following allo-HSCT.
📍 Espace Inkermann Chatillon, Lille, France